Phreesia (NYSE:PHR) Price Target Lowered to $22.00 at Canaccord Genuity Group

Phreesia (NYSE:PHR) had its target price reduced by investment analysts at Canaccord Genuity Group from $33.00 to $22.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 92.41% from the stock’s previous close.

A number of other brokerages also recently weighed in on PHR. Barclays cut their target price on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 16th. Citigroup reissued a “neutral” rating and issued a $10.00 price objective on shares of Phreesia in a research report on Tuesday. Truist Financial restated a “hold” rating and issued a $11.00 price objective on shares of Phreesia in a research note on Tuesday. Royal Bank Of Canada initiated coverage on Phreesia in a research report on Friday, January 9th. They set a “moderate buy” rating and a $26.00 target price for the company. Finally, Robert W. Baird reiterated a “neutral” rating and set a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday. Thirteen research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $22.71.

Phreesia Stock Performance

NYSE PHR opened at $11.43 on Tuesday. The company has a fifty day moving average price of $12.51 and a 200-day moving average price of $17.68. The firm has a market cap of $689.36 million, a price-to-earnings ratio of -114.33 and a beta of 0.67. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. Phreesia has a 1 year low of $10.75 and a 1 year high of $32.76.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, March 30th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.05). Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The firm had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter last year, the firm posted ($0.11) earnings per share. The firm’s revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, equities research analysts predict that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Transactions at Phreesia

In other Phreesia news, insider Evan Roberts sold 6,317 shares of the firm’s stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $107,452.17. Following the completion of the sale, the insider directly owned 834,632 shares of the company’s stock, valued at $14,197,090.32. This trade represents a 0.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider David Linetsky sold 6,106 shares of the business’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total value of $103,863.06. Following the completion of the sale, the insider owned 231,723 shares in the company, valued at approximately $3,941,608.23. The trade was a 2.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 70,358 shares of company stock valued at $1,123,569 in the last three months. 5.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Phreesia

Several large investors have recently modified their holdings of the business. Hsbc Holdings PLC raised its position in shares of Phreesia by 96.2% in the fourth quarter. Hsbc Holdings PLC now owns 46,558 shares of the company’s stock valued at $786,000 after purchasing an additional 22,829 shares during the period. Rockefeller Capital Management L.P. boosted its holdings in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after buying an additional 2,149 shares during the period. Alpine Global Management LLC bought a new position in Phreesia in the 4th quarter worth approximately $179,000. Invesco Ltd. grew its stake in Phreesia by 13.1% in the 4th quarter. Invesco Ltd. now owns 82,176 shares of the company’s stock valued at $1,390,000 after buying an additional 9,514 shares in the last quarter. Finally, State of Tennessee Department of Treasury purchased a new position in Phreesia in the 4th quarter valued at approximately $202,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
• Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
• Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
• Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
• Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.